Skip to main content
Clinical Trials/IRCT20230803059017N1
IRCT20230803059017N1
Not Yet Recruiting
Phase 2

Comparison of vestibular rehabilitation methods and the use of serotonin norepinephrine reuptake inhibitors (venlafaxine) in the treatment of patients with persistent postural perceptual dizziness.

Esfahan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Persistent postural perceptual dizziness.
Sponsor
Esfahan University of Medical Sciences
Enrollment
60
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Comparison of two vestibular rehabilitation methods and the use of serotonin norepinephrine reuptake inhibitors (venlafaxine) in the treatment of patients with persistent postural perceptual dizziness.
  • Age over 18 years and under 65 years
  • Informed consent to participate in the study
  • Dizziness Handicap Inventory (DHI) \>16

Exclusion Criteria

  • Having psychiatric and/or cognitive disorders that prevent understanding tests and questionnaires.
  • Using drugs that cause dizziness
  • Having brain structural disorders
  • Having high blood pressure
  • Having a history of heart disease such as heart failure and heart attack
  • hyperthyroidism

Outcomes

Primary Outcomes

Not specified

Similar Trials